porcin
circoviru
type
caus
agent
postwean
multisystem
wast
syndrom
pmw
multifactori
diseas
affect
nurseri
fatten
pig
et
al
syndrom
character
progress
loss
weight
secondari
opportunist
infect
report
common
carrasco
et
al
clark
main
histolog
lesion
consist
extens
lymphocyt
deplet
togeth
histiocyt
andor
multinucl
giant
cell
infiltr
clark
rosel
et
al
thu
whole
pictur
diseas
highli
suggest
acquir
immunodefici
veterinari
immunolog
immunopatholog
interact
porcin
circoviru
type
pig
immun
system
suggest
determin
event
pathogenesi
postwean
multisystem
wast
syndrom
pmw
gain
insight
host
immun
mechan
develop
upon
infect
earli
innat
adapt
immun
respons
examin
caesareanderiv
colostrumdepriv
piglet
use
subclin
infect
model
combin
lipopolysaccharid
lp
potenti
immunostimul
factor
use
lp
show
signific
effect
cours
infect
evolut
immunolog
paramet
evalu
ex
vivo
respons
detect
earli
day
postinfect
pi
consist
elev
plasmat
level
interleukin
il
pig
follow
increas
plasmat
ifna
day
pi
regard
one
pig
posit
day
pi
pig
one
viremia
persist
end
studi
vitro
cytokin
determin
show
regardless
treatment
administr
pig
releas
observ
peripher
blood
mononuclear
cell
pbmc
cultur
stimul
seroconvert
measur
immunoperoxidas
monolay
assay
ipma
occur
day
pi
wherea
neutral
antibodi
na
appear
day
pi
dna
first
detect
serum
day
pi
reach
peak
viremia
day
pi
follow
drop
viral
load
found
coincid
appear
ifngsecret
cell
na
result
present
work
suggest
viral
clearanc
might
mediat
develop
contribut
na
elsevi
bv
right
reserv
sever
studi
suggest
interact
immun
system
key
event
pathogenesi
pmw
infect
monocyticlineag
cell
gilpin
et
al
rosel
et
al
vincent
et
al
longlast
persist
within
macrophag
dendrit
cell
dc
suggest
potenti
mechan
dissemin
throughout
bodi
addit
impair
abil
peripher
blood
mononuclear
cell
pbmc
respond
mitogen
darwich
et
al
viral
dna
shown
block
activ
natur
interferonproduc
cell
nipc
produc
ifna
turn
affect
abil
cell
mediat
antivir
respons
upon
infect
vincent
et
al
besid
demonstr
induc
secret
vitro
cultur
pbmc
darwich
et
al
kekarainen
et
al
lead
downregul
cytokin
produc
recal
antigen
respons
kekarainen
et
al
author
latter
studi
suggest
involv
suppress
th
respons
observ
cours
pmw
hypothesi
also
support
work
perform
blood
sampl
inocul
pig
elev
plasma
correl
either
develop
pmw
stevenson
et
al
increas
load
serum
darwich
et
al
altogeth
data
suggest
mechan
use
counteract
host
immun
defenc
like
lie
immunomodulatori
activ
viral
compon
infect
subclin
differ
factor
postul
potenti
trigger
develop
diseas
experiment
success
model
use
reproduc
pmw
includ
coinocul
porcin
parvoviru
use
substanc
modul
immun
system
keyhol
limpet
haemocyanin
incomplet
freund
adjuv
krakowka
et
al
occasion
pmw
also
reproduc
use
alon
kennedi
et
al
although
none
model
consist
repeatedli
demonstr
convent
pig
evid
point
toward
alter
immun
respons
induc
yet
unknown
factor
trigger
factor
pmw
develop
lipopolysaccharid
lp
use
previou
work
aim
reproduc
viralinduc
multifactori
respiratori
diseas
inocul
pig
infect
either
porcin
respiratori
reproduct
syndrom
viru
prrsv
porcin
respiratori
coronaviru
prcv
van
gucht
et
al
result
studi
demonstr
inmunomodulatori
effect
lp
seen
overexpress
certain
proinflammatori
cytokin
found
correl
clinic
diseas
addit
anoth
studi
perform
chang
et
al
demonstr
lp
abl
vitro
induc
upregul
replic
swine
pulmonari
macrophag
aim
present
work
gain
insight
immun
respons
gener
upon
infect
studi
innat
adapt
immun
respons
experiment
inocul
pig
either
use
alon
combin
lp
potenti
immunostimul
paramet
evalu
use
set
refer
pattern
later
compar
event
take
place
cours
pmw
detail
sourc
hous
anim
well
experiment
condit
previous
describ
fernand
et
al
briefli
fiftyfour
colostrumdepriv
caesareanderiv
cdcd
piglet
includ
studi
pig
randomli
distribut
four
group
name
n
b
n
c
n
n
group
pig
kept
uninocul
control
group
b
anim
intraperiton
inocul
mgkg
lp
salmonella
typhimurium
sigmaaldrich
group
c
pig
inocul
tcid
burgo
strain
ml
oral
ml
nasal
produc
cell
group
pig
receiv
simultan
lp
dose
state
order
studi
event
take
place
earli
stage
infect
thirtytwo
piglet
sequenti
necropsi
within
first
day
experi
remain
pig
follow
throughout
experiment
period
bled
day
postinocul
pi
serum
pbmc
collect
experiment
period
clinic
sign
monitor
daili
pig
weight
three
time
week
day
pi
euthanasia
tabl
summar
experiment
design
anim
care
activ
studi
procedur
conduct
accord
guidelin
good
experiment
practic
gep
approv
ethic
anim
welfar
committe
universitat
de
barcelona
viral
load
determin
serum
mean
quantit
taqman
pcr
qpcr
olvera
et
al
tissu
use
situ
hybridis
ish
procedur
rosel
et
al
antibodymedi
respons
assess
immunoperoxidas
monolay
assay
ipma
viral
neutral
test
describ
elsewher
level
ifna
tnfa
plasma
sampl
examin
mean
captur
elisa
develop
use
commerci
avail
antibodi
antiifna
antibodi
pbl
biomed
laboratori
piscataway
nj
usa
antitnfa
r
system
spain
biosourc
spain
elisa
cutoff
valu
calcul
averag
optic
densiti
neg
control
plu
three
standard
deviat
cytokin
concentr
determin
use
regress
line
built
optic
densiti
cytokin
standard
use
test
pbmc
separ
whole
blood
gradient
densiti
centrifug
use
histopaqu
sigmaaldrich
cell
cultur
h
co
cellswel
presenc
either
moi
tcid
cell
phytohaemagglutinin
pha
mgml
mock
stimul
cell
cultur
supernat
uninfect
cell
cultur
done
least
triplic
supernat
correspond
anim
stimulu
mix
analysi
captur
elisa
ifng
bd
madrid
spain
biosourc
spain
perform
cytokin
concentr
calcul
explain
frequenc
ifngsecret
cell
pbmc
determin
elispot
day
pi
use
commerci
mab
swine
ifng
cytoset
kit
biosourc
spain
follow
previous
describ
protocol
mateu
briefli
flat
bottom
plate
costar
corn
usa
coat
overnight
antiifng
antibodi
mgml
carbonatebicarbon
buffer
ph
plate
wash
three
time
phosphatebuff
salin
pb
block
pb
contain
foetal
bovin
serum
fb
h
remov
block
solut
ml
contain
pbmc
dispens
per
well
stimul
either
moi
pha
mgml
mock
stimul
h
c
presenc
co
cell
remov
well
incub
hour
ml
biotinyl
antibodi
mgml
pb
contain
tween
bovin
serum
albumin
pbstbsa
three
wash
pbst
plate
incub
h
streptavidinhrp
biosourc
spain
mgml
pbstbsa
final
insolubl
tmb
blue
calbiochem
spain
use
reveal
reaction
calcul
subtract
number
spot
count
mockstimul
well
one
result
express
number
ifngsc
per
million
pbmc
pbmc
subset
phenotyp
character
flowcytometri
bd
bd
southern
biotech
southern
biotech
southern
biotech
cell
fifti
microlit
cell
suspens
adjust
cell
per
ml
flowcytometri
medium
fcm
pb
contain
bsa
place
plate
incub
min
ml
mab
follow
two
wash
fcm
except
alreadi
conjug
fitc
pe
rabbit
f
ab
antimous
igfitc
dako
denmark
use
secondari
antibodi
final
pmbc
wash
twice
fix
fmc
contain
paraformaldehyd
analysi
perform
use
epicsxl
mcl
flow
cytomet
beckmancoult
usa
irrelev
isotypematch
antibodi
use
background
control
statist
analys
compar
mean
differ
paramet
among
group
perform
use
glm
procedur
sa
softwar
sa
institut
inc
cari
nc
usa
differ
attribut
effect
lp
detect
data
analys
consid
inocul
classificatori
variabl
group
b
consid
control
group
group
c
one
signific
level
set
detail
clinic
patholog
data
found
fernand
et
al
end
studi
day
pi
group
show
lower
mean
bodi
weight
ae
kg
group
c
ae
kg
compar
control
one
ae
kg
group
ae
kg
b
p
howev
none
pig
develop
clinic
sign
compat
pmw
throughout
whole
studi
one
day
inocul
pig
receiv
lp
group
b
significantli
higher
rectal
bodi
temperatur
compar
group
c
ae
vs
ae
p
onward
differ
rectal
temperatur
observ
among
group
regard
patholog
studi
anim
euthan
within
first
day
pi
detect
viru
tissu
ish
contrast
piglet
necropsi
end
studi
day
pi
anim
show
presenc
mild
lesion
lymphoid
tissu
togeth
low
moder
amount
dna
lesion
determin
ish
group
c
group
result
qpcr
show
dna
firstli
appear
sera
pig
day
pi
increas
titr
day
pi
group
c
ae
viral
copiesml
day
pi
group
ae
viral
copiesml
p
pig
remain
free
viru
along
studi
develop
humor
respons
start
pig
group
c
appear
ipmadetect
antibodi
day
pi
increas
titr
day
pi
mean
ipma
titr
ae
log
seroconvers
na
occur
day
pi
mean
titr
ae
log
differ
group
c
notic
regard
ipma
na
titr
piglet
transient
increas
plasma
level
ae
pgml
day
pi
wherea
uninocul
control
remain
neg
time
fade
level
ifna
start
detect
serum
pig
thu
day
pi
one
anim
group
c
one
posit
cytokin
day
pi
sera
pig
detect
ifna
group
c
ae
pgml
group
ae
pgml
later
posit
result
sporad
detect
fig
regard
detect
serum
one
anim
group
c
posit
day
pi
pgml
tnfa
piglet
neg
cytokin
detect
sporad
regardless
inocul
statu
data
shown
vitro
treatment
pbmc
induct
ifng
observ
hand
level
detect
supernat
pbmc
stimul
significantli
higher
detect
mockstimul
cultur
p
inde
releas
induc
viru
observ
independ
administr
treatment
signific
differ
although
individu
result
show
certain
variat
within
group
along
studi
thu
group
pig
detect
posit
develop
ifngsc
observ
group
c
start
day
pi
thu
day
pi
pig
group
c
group
posit
mean
frequenc
ae
ae
per
million
pbmc
p
respect
day
pi
valu
ae
ae
p
none
pig
group
b
posit
result
ifng
elispot
studi
fig
summar
result
develop
ifngsc
antibodi
viremia
group
c
flowcytometri
analys
chang
rel
proport
cell
subset
sporad
transient
could
attribut
treatment
receiv
howev
pig
show
decreas
rel
proport
cell
ae
vs
ae
p
well
lymphocyt
ae
vs
ae
p
day
pi
respect
compar
pig
addit
downshift
cell
observ
group
compar
control
day
ae
vs
ae
p
ae
vs
ae
p
respect
day
pi
differ
disappear
pathogenesi
pmw
fulli
understood
yet
singl
paramet
group
paramet
use
reliabl
predictor
develop
diseas
previou
report
suggest
complex
hostviru
interact
subsequ
immun
respons
gener
might
critic
determin
understand
diseas
meert
et
al
stevenson
et
al
vincent
et
al
present
studi
tri
character
paramet
innat
adapt
immun
respons
anim
withstand
infect
without
develop
clinic
diseas
date
although
reproduct
pmw
achiev
use
sever
experiment
model
et
al
none
demonstr
consist
repeat
convent
pig
among
use
immunostimul
coinfect
follow
infect
appar
success
strategi
experiment
reproduc
clinic
diseas
suggest
activ
immun
system
potenti
trigger
factor
pmw
et
al
present
studi
effect
immunostimul
cours
infect
evalu
cdcd
piglet
inject
lp
simultan
inocul
although
lp
claim
posit
effect
replic
pulmonari
macrophag
chang
et
al
data
show
signific
effect
lp
evolut
infect
fernand
et
al
immunolog
paramet
evalu
throughout
experi
result
might
suggest
lpsinduc
viral
replic
report
vitro
appar
occur
vivo
extens
enough
trigger
pmw
present
experiment
condit
nevertheless
studi
local
effect
lp
target
tissu
perform
conclud
sinc
signific
induct
plasmat
proinflammatori
cytokin
attribut
lp
administr
detect
regard
innat
immun
respons
earliest
event
detect
follow
infect
increas
plasma
level
day
pi
abil
induc
product
porcin
alveolar
macrophag
pbmc
previous
report
chang
et
al
darwich
et
al
agre
inflammatori
natur
lesion
usual
seen
anim
present
studi
proinflammatori
cytokin
tnfa
detect
serum
consist
pattern
howev
lack
detect
cytokin
plasma
exclud
play
role
earli
phase
infect
sinc
could
act
local
site
viral
replic
without
reach
level
high
enough
detect
serum
contrast
clear
ifna
respons
observ
pig
day
pi
ifna
consid
crucial
cytokin
host
antivir
defenc
involv
innat
respons
also
regul
adapt
immun
gener
upon
viral
infect
inde
abil
counter
ifnamedi
respons
differ
pathway
therebi
interfer
immun
mechan
host
report
sever
virus
garciasastr
biron
case
recent
studi
show
motif
may
inhibit
induc
ifna
respons
vincent
et
al
wikstrom
et
al
depend
cell
subset
studi
structur
cpg
vincent
et
al
report
abl
block
ifna
induct
nipc
suggest
inmunomodulatori
activ
key
event
pathogenesi
pmw
respect
anim
withstand
infect
without
develop
clinic
diseas
abl
counteract
inhibitori
activ
probabl
mean
strong
innat
respons
present
studi
substanti
amount
ifna
detect
plasma
pig
earli
stage
infect
indic
develop
earli
innat
respons
viru
gener
fact
genom
neither
lesion
found
tissu
earli
necropsi
pig
might
attribut
abil
persist
monocyticlineag
cell
without
activ
replic
therefor
undetect
standard
techniqu
result
togeth
fact
known
mediat
inhibit
nipc
respons
suggest
balanc
host
abil
mount
proper
innat
antivir
respons
viru
abil
dampen
might
determin
infect
evolut
trigger
diseas
elev
level
plasma
detect
one
pig
day
pi
contrast
vitro
result
show
induct
releas
respons
stimul
pbmc
regardless
treatment
administr
pig
involv
pathogenesi
pmw
suggest
sever
studi
darwich
et
al
found
overexpress
mrna
thymu
pmwsaffect
pig
correl
lymphoid
lesion
also
cytokin
profil
evalu
blood
sampl
inocul
pig
show
associ
elev
plasma
level
develop
pmw
stevenson
et
al
vitro
demonstr
induc
secret
pbmc
cultur
turn
lead
repress
cytokin
kekarainen
et
al
altogeth
data
suggest
abil
induc
might
contribut
immunosuppress
statu
observ
cours
pmw
studi
none
pig
develop
clinic
diseas
viremia
decreas
day
pig
one
viremia
persist
end
studi
data
shown
interestingli
pig
one
detect
serum
also
one
lowest
ifna
respons
gener
result
suggest
pig
control
progress
infect
might
counteract
abil
induc
releas
probabl
mean
strong
ifna
respons
regard
adapt
respons
ipma
antibodi
appear
day
pi
wherea
na
appear
day
later
ineffici
delay
develop
antibodymedi
immun
previous
correl
high
level
replic
outcom
clinic
diseas
meert
et
al
okuda
et
al
howev
certain
delay
neutral
respons
also
observ
subclin
infect
pig
pmw
develop
cytometr
analysi
indic
infect
pig
suffer
downshift
cell
day
pi
valu
return
normal
end
studi
chang
pbmc
subset
pig
develop
diseas
previous
report
darwich
et
al
nielsen
et
al
differ
one
observ
pmwsaffect
one
nielsen
et
al
wherea
leukopenia
observ
pig
infect
subclin
seem
transient
leukopenia
pmwsaffect
one
appear
earlier
stronger
correl
appear
clinic
diseas
role
specif
cellular
defenc
mechan
provid
protect
pmw
elucid
yet
herein
describ
first
time
develop
ifngsc
respons
infect
ifng
consid
key
cytokin
polaris
control
differenti
cell
effector
cytokin
mediat
cellular
immun
viral
infect
present
studi
develop
ifngsc
subclin
infect
anim
start
day
pi
coincident
decreas
viral
load
blood
result
suggest
cellmedi
respons
measur
ifngsc
might
also
contribut
togeth
develop
na
clearanc
conclus
result
present
studi
suggest
pig
earli
innat
ifna
respons
togeth
develop
na
may
adequ
predictor
evolut
infect
explor
experi
aim
elucid
mechan
lie
behind
differ
clinic
outcom
infect
pig
